← Back to Search

Cannabinoid

Cannabidiol for Anxiety Disorders

Phase < 1
Waitlist Available
Research Sponsored by University of Connecticut
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* 18-50 years of age
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 20 minutes

Summary

This trial will test if CBD can help college students with social anxiety overcome their fear. Participants will be conditioned to fear a face followed by a shock, then half will take CBD while the other half takes

Who is the study for?
This trial is for college undergraduates aged 18-50 at the University of Connecticut who show high levels of social anxiety. Participants must not have any conditions that would exclude them from safely receiving CBD or a placebo.
What is being tested?
The study tests if a single dose of Cannabidiol (CBD) can help reduce fear and anxiety compared to a placebo. It measures how participants respond to faces associated with mild shocks after taking either CBD or a sugar pill, without further shocks.
What are the potential side effects?
Potential side effects of CBD include tiredness, diarrhea, changes in appetite/weight, and possibly affecting liver enzymes. The placebo should have no active effects but may cause reactions based on belief it's real.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~20 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 20 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Electrodermal activity

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: CannabidiolExperimental Treatment1 Intervention
600 mg Cannabidiol Isolate Gel Capsules / participant. One-time dose.
Group II: PlaceboPlacebo Group1 Intervention
Same number of placebo capsules / participant. One-time dose.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cannabidiol Oral Product
2020
Completed Phase 4
~90

Find a Location

Who is running the clinical trial?

University of ConnecticutLead Sponsor
192 Previous Clinical Trials
160,720 Total Patients Enrolled
~107 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top